MANISCALCHI, A.; BENZI JUNCOS, O.N.; CONDE, M.; FUNK, M.I.; FERMENTO, M.E.; FACCHINETTI, M.M.; CURINO, A.; URANGA, R.; ALZA, N.P.; SALVADOR, G.

New insights on neurodegeneration triggered by iron accumulation: Intersections with neutral lipid metabolism, ferroptosis, and motor impairment

Redox Biology; Año: 2024 vol. 71

CONDE, M.; ALZA, N.P.; FUNK, M.I.; MANISCALCHI, A.; BENZI JUNCOS, O.N.; BERGE, I; URANGA, R.; SALVADOR, G.

alpha-Synuclein attenuates Maneb neurotoxicity through the modulation of redox-sensitive transcription factors

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY; Lugar: Austin, Texas; Año: 2023

ALZA, N.P.; CONDE, M.; SCODELARO BILBAO, P.G.; SALVADOR, G.

Neutral lipids as early biomarkers of cellular fate: the case of alpha-synuclein overexpression

Cell Death and Disease; Año: 2021 vol. 12

ALZA, NATALIA P.; IGLESIAS GONZÁLEZ, PABLO A.; CONDE, MELISA A.; URANGA, ROMINA M.; SALVADOR, GABRIELA A.

Lipids at the crossroad of alpha;-synuclein function and dysfunction: Biological and pathological implications

Frontiers in Cellular Neuroscience; Año: 2019 vol. 13

SANCHEZ CAMPOS, S.; ALZA, N.P.; SALVADOR, G.

Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS; Lugar: Amsterdam; Año: 2018 vol. 655 p. 43 - 54

CONDE, M. *(PRIMERA AUTORÍA COMPARTIDA); ALZA, N.P. *(PRIMERA AUTORÍA COMPARTIDA); IGLESIAS GONZÁLEZ, P.A.; SCODELARO BILBAO, P.G.; SANCHEZ CAMPOS, S.; URANGA, R.; SALVADOR, G.

Phospholipase D1 downregulation by a-synuclein: Implications for neurodegeneration in Parkinson´s disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS; Lugar: Amsterdam; Año: 2018

CAVALLARO, V.; REZNIKOVÁ. E.; JORDAB, R.; ALZA, N.P.; MURRAY, A.P.; KRYSTOF, V.

Semisynthetic esters of 17-hydroxycativic acid with in vitro cytotoxic activity against leukemia cell lines

BIOL. PHARM. BULL.; Lugar: Tokyo; Año: 2017 vol. 40 p. 1923 - 1928

ALZA, N.P.; MURRAY, A.P.; SALVADOR, G.

Cativic acid-caffeic acid hybrid exerts cytotoxic effects and induces apoptotic death in human neuroblastoma cells

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY; Lugar: Berlin; Año: 2017

URANGA, R.; ALZA, N.P.; CONDE, M.; ANTOLLINI, S.; SALVADOR, G.

Phosphoinositides: Two-Path Signaling in Neuronal Response to Oligomeric Amyloid Beta Peptide

MOLECULAR NEUROBIOLOGY; Lugar: Oregon; Año: 2017

ALZA, N.P.; MURRAY, A.P.

Chemical Constituents and Acetylcholinesterase Inhibition of Senecio ventanensis Cabrera (Asteraceae)

Records of Natural Products; Año: 2016 vol. 10 p. 513 - 518

ALZA, N.P.; RICHMOND, V. ; BAIER, C.J.; FREIRE, E.; BAGGIO, R.; MURRAY, A.P.

Synthesis and Cholinesterase Inhibition of Cativic Acid Derivatives

BIOORGANIC & MEDICINAL CHEMISTRY.; Lugar: Amsterdam; Año: 2014 vol. 22 p. 3838 - 3849

ALZA, N.P.; PFERSCHY-WENZIG, E.; ORTMANN, S.; KRETSCHMER, N.; KUNERT, O.; RECHBERGER, R.; BAUER, R.; MURRAY, A.P.

Inhibition of NO production in Grindelia argentina and isolation of three new cytotoxic saponins

Chemistry and Biodiversity; Lugar: Zurich; Año: 2014 vol. 11 p. 311 - 322

CAVALLARO, V.; ALZA, N.P.; MURRAY, M.G.; MURRAY, A.P.

Alkaloids from Habranthus tubispathus and H. jamesonii, two Amaryllidaceae with Acetyl- and Butyrylcholinesterase Inhibition Activity

NATURAL PRODUCT COMMUNICATIONS; Lugar: Westerville, Ohio; Año: 2014 vol. 9 p. 159 - 162

MURRAY, A.P.; FARAONI, M.B.; CASTRO, M.J.; ALZA, N.P.; CAVALLARO, V.

Natural AChE inhibitors from plants and their contribution to Alzheimer´s disease therapy

CURRENT NEUROPHARMACOLOGY; Lugar: Oak Park; Año: 2013 vol. 11 p. 388 - 413

ALZA, N.P.; CAMBI, V.

Control de Calidad de Mezclas de Drogas Vegetales comercializadas como Sedantes en Bahía Blanca, Argentina

ACTA FARM. BONAERENSE; Lugar: La Plata; Año: 2009 vol. 28 p. 560 - 567